To date, only case reports of mGluR5 antibody-overlapping patients with encephalitis have been documented, and the lack of large-scale studies has resulted in an inadequate evaluation of long-term outcomes and the effect of immunotherapy. This evidence concerns the gene GRM5 and viral encephalitis.